Literature DB >> 19482641

Enteropeptidase, a type II transmembrane serine protease.

X Long Zheng1, Yasunori Kitamoto, J Evan Sadler.   

Abstract

Enteropeptidase, a type II transmembrane serine protease, is localized to the brush border of the duodenal and jejunal mucosa. It is synthesized as a zymogen (proenteropeptidase) that requires activation by another protease, either trypsin or possibly duodenase. Active enteropeptidase then converts the pancreatic precursor, trypsinogen, to trypsin by cleavage of the specific trypsinogen activation peptide, Asp-Asp-Asp-Asp-Lys- Ile that is highly conserved in vertebrates. Trypsin, in turn, activates other digestive zymogens such as chymotrypsinogen, proelastase, procarboxypeptidase and prolipase in the lumen of the gut. The important biological function of enteropeptidase is highlighted by the manifestation of severe diarrhea, failure to thrive, hypoproteinemia and edema as a result of congenital deficiency of enteropeptidase activity in the gut. Conversely, duodenopancreatic reflux of proteolytically active enteropeptidase may cause acute and chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482641     DOI: 10.2741/E23

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  23 in total

1.  Gut pH as a limiting factor for digestive proteolysis in cultured juveniles of the gilthead sea bream (Sparus aurata).

Authors:  Lorenzo Márquez; Rocío Robles; Gabriel A Morales; Francisco J Moyano
Journal:  Fish Physiol Biochem       Date:  2011-11-16       Impact factor: 2.794

Review 2.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

3.  Ribonuclease S redux.

Authors:  Rex W Watkins; Ulrich Arnold; Ronald T Raines
Journal:  Chem Commun (Camb)       Date:  2010-11-16       Impact factor: 6.222

Review 4.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

Review 5.  Corin in clinical laboratory diagnostics.

Authors:  Ningzheng Dong; Shenghan Chen; Wei Wang; Yiqing Zhou; Qingyu Wu
Journal:  Clin Chim Acta       Date:  2011-11-07       Impact factor: 3.786

6.  Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity.

Authors:  Zenichi Ikeda; Keiko Kakegawa; Fumiaki Kikuchi; Sachiko Itono; Hideyuki Oki; Hiroaki Yashiro; Hideyuki Hiyoshi; Kazue Tsuchimori; Kenichi Hamagami; Masanori Watanabe; Masako Sasaki; Youko Ishihara; Kimio Tohyama; Tomoyuki Kitazaki; Tsuyoshi Maekawa; Minoru Sasaki
Journal:  J Med Chem       Date:  2022-06-10       Impact factor: 8.039

Review 7.  Membrane-anchored serine proteases in health and disease.

Authors:  Toni M Antalis; Thomas H Bugge; Qingyu Wu
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

8.  Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HAT.

Authors:  Katiuchia Uzzun Sales; John P Hobson; Rebecca Wagenaar-Miller; Roman Szabo; Amber L Rasmussen; Alexandra Bey; Maham F Shah; Alfredo A Molinolo; Thomas H Bugge
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

9.  Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase.

Authors:  Thomas A Prohaska; Felix C Wahlmüller; Margareta Furtmüller; Margarethe Geiger
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

10.  Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.

Authors:  Roman Szabo; Katiuchia Uzzun Sales; Peter Kosa; Natalia A Shylo; Sine Godiksen; Karina K Hansen; Stine Friis; J Silvio Gutkind; Lotte K Vogel; Edith Hummler; Eric Camerer; Thomas H Bugge
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.